Account
Inquiry
Retatrutide (LY-3437943) is a novel peptide compound developed for research purposes in the field of metabolic disorders and weight management. This GLP-1 receptor agonist peptide features a unique molecular structure with modifications that enhance its stability and biological activity.
The peptide contains two significant structural modifications: replacement of Gly with 2-aminoisobutyric acid (Aib) at position 2, and attachment of octadecanoic diacid to the side chain of Lys-26 through a polyethylene glycol (PEG) spacer. These modifications contribute to increased resistance to DPP-4 degradation and improved binding affinity.
Retatrutide is supplied as a lyophilized powder in sterile vials with 99% purity, making it suitable for various research applications. The product is carefully packaged to ensure stability and maintain its research-grade quality.
For laboratory research use only. This product is not intended for human consumption or diagnostic use.
